As of 2026-04-13, the Relative Valuation of Catalyst Pharmaceuticals Inc (CPRX) is 33.43 USD. This relative valuation is based on P/E multiples. With the latest stock price at 24.94 USD, the upside of Catalyst Pharmaceuticals Inc based on Relative Valuation is 34.0%.
The range of the Relative Valuation is 29.05 - 38.49 USD.
| Range | Selected | |
| Trailing P/E multiples | 17.2x - 21.1x | 19.0x |
| Forward P/E multiples | 15.8x - 21.0x | 18.3x |
| Fair Price | 29.05 - 38.49 | 33.43 |
| Upside | 16.5% - 54.3% | 34.0% |
| Date | P/E |
| 2026-04-10 | 14.21 |
| 2026-04-09 | 14.59 |
| 2026-04-08 | 14.42 |
| 2026-04-07 | 14.24 |
| 2026-04-06 | 14.23 |
| 2026-04-02 | 14.07 |
| 2026-04-01 | 14.14 |
| 2026-03-31 | 14.11 |
| 2026-03-30 | 13.55 |
| 2026-03-27 | 13.33 |
| 2026-03-26 | 13.82 |
| 2026-03-25 | 13.56 |
| 2026-03-24 | 13.14 |
| 2026-03-23 | 13.29 |
| 2026-03-20 | 12.99 |
| 2026-03-19 | 12.72 |
| 2026-03-18 | 13.00 |
| 2026-03-17 | 13.29 |
| 2026-03-16 | 13.28 |
| 2026-03-13 | 13.24 |
| 2026-03-12 | 13.33 |
| 2026-03-11 | 13.91 |
| 2026-03-10 | 14.11 |
| 2026-03-09 | 14.13 |
| 2026-03-06 | 13.81 |
| 2026-03-05 | 13.86 |
| 2026-03-04 | 14.07 |
| 2026-03-03 | 13.63 |
| 2026-03-02 | 13.61 |
| 2026-02-27 | 13.15 |
| 2026-02-26 | 14.18 |
| 2026-02-25 | 14.16 |
| 2026-02-24 | 13.78 |
| 2026-02-23 | 13.74 |
| 2026-02-20 | 13.85 |
| 2026-02-19 | 13.91 |
| 2026-02-18 | 13.84 |
| 2026-02-17 | 14.04 |
| 2026-02-13 | 13.86 |
| 2026-02-12 | 13.45 |
| 2026-02-11 | 13.63 |
| 2026-02-10 | 13.83 |
| 2026-02-09 | 13.93 |
| 2026-02-06 | 13.93 |
| 2026-02-05 | 13.62 |
| 2026-02-04 | 14.28 |
| 2026-02-03 | 14.37 |
| 2026-02-02 | 14.24 |
| 2026-01-30 | 13.85 |
| 2026-01-29 | 14.01 |